US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
CytomX Therapeutics Inc (CTMX)
CytomX Therapeutics Inc (CTMX) ニュース

CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/25	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/16	10 : 40	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/11	05 : 05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/09	05 : 15	GlobeNewswire Inc.	CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/09	05 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/09	05 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/08/01	21 : 00	GlobeNewswire Inc.	CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/07/21	06 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/07/21	06 : 17	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/07/20	22 : 00	GlobeNewswire Inc.	CytomX Therapeutics Announces New Employment Inducement Grants	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/07/17	21 : 00	GlobeNewswire Inc.	CytomX Therapeutics Appoints Yu-Waye (Wayne) Chu, M.D., as Chief Medical Officer	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/30	21 : 00	GlobeNewswire Inc.	CytomX Therapeutics Announces $30 Million Private Placement from BVF Partners L.P.	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/21	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/17	06 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/06/02	05 : 05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the Jefferies Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/05/24	05 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/05/10	05 : 15	GlobeNewswire Inc.	CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/05/10	05 : 13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/05/10	05 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/05/02	05 : 01	GlobeNewswire Inc.	CytomX Therapeutics to Report First Quarter 2023 Financial Results on May 9, 2023	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/04/28	05 : 22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/04/28	05 : 21	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/04/26	05 : 05	GlobeNewswire Inc.	CytomX Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/03/30	08 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2023/03/30	08 : 51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:CTMX	CytomX Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:CTMX

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 次へ >>

Verizon Communications

BNP Paribas (QX)

Gold vs US Dollar

JP Morgan Chase

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約